LALREAN, A Latin American Network Of Excellence For The Study Of Liver Diseases, Enters Into A Collaboration With Advanced Biological Laboratories SA (ABL) To Enhance Regional Understanding Of The Burden Of Hepatitis C In Latin America

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LUXEMBOURG--(BUSINESS WIRE)--Advanced Biological Laboratories (ABL) S.A., a Luxembourg-based company, is pleased to announce the signing of a licensing and collaboration agreement with LALREAN (Latin American Liver Research Awareness and Educational Network), a Latin American research network of excellence for study of liver diseases representing an active cohort of over 7,000 HCV infected-patients involving some 18 treatment centres in five countries.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC